Biosimilars in Oncology: A Payor, Provider, and Community/C-Suite Perspective

Kevin Knopf

CE Synergy Panel Discussion, 05/06/2021

Learning Objectives:

  1. Kevin Knopf, MD, VIVIO Director of Clinical Innovation is on this panel on the current state of affairs for the global and US oncology biosimilar market.
  2. Identify existing and/or anticipated barriers to adoption of biosimilars from various stakeholders
    (payor, provider, c-suite, community)
  3. Discuss strategies and best practice solutions to help optimize biosimilar adoption
  4. Describe current and future policies or regulations impacting biosimilar ecosystem

Strategies for Overcoming Existing or Anticipated Barriers
Panel Discussion:
• Academic Health System Perspective
• Community Cancer Center Perspective
• Payer Perspective

Panelists: Kevin Knopf, MD, Kathy Oubre, MS, Desiree Otenti, MNS